Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Long-term survival of a patient with liver metastases from clear cell gastric adenocarcinoma after multimodality treatment including interventional oncology techniques : case report
Avtorji:ID Jugovec, Vesna (Avtor)
ID Benedik, Jernej (Avtor)
ID Jeruc, Jera (Avtor)
ID Popović, Peter (Avtor)
Datoteke:URL URL - Izvorni URL, za dostop obiščite https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900438/
 
.pdf PDF - Predstavitvena datoteka, prenos (1,76 MB)
MD5: 752B7A0FCDF73EF3F3D0F88EC20F9067
 
Jezik:Angleški jezik
Tipologija:1.03 - Drugi znanstveni članki
Organizacija:Logo OI - Onkološki inštitut Ljubljana
Povzetek:Background: Gastric cancer (GC) is the fourth most common cancer and the third leading cancer-related cause of death worldwide since most patients are diagnosed at an advanced stage. The majority of GCs are adenocarcinomas (ACs), and the poorly characterized clear cell AC represents a unique subgroup of GCs and is an independent marker of poor prognosis. Even though the prognosis for patients with advanced GC is poor we present a report of a patient with long-term survival despite having liver metastases from clear cell gastric AC. Case presentation: A 45-year-old male with clear cell gastric AC underwent subtotal gastrectomy and postoperative chemoradiation. Only a year and a half after his initial treatment the disease spread to his liver. He received two lines of chemotherapy treatment within the next two years before a right hepatectomy was suggested. Due to an initially insufficient future liver remnant (FLR), transarterial chemoembolization (TACE) and portal vein embolization (PVE) were performed, which made the surgical procedure possible. Shortly after a disease progression in the remaining liver was detected. In the following three years the patient was treated with a carefully planned combination of systemic therapy and different interventional oncology techniques including selective internal radiation therapy (SIRT) and TACE. And as illustrated, an attentive, patient-tailored, multimodality treatment approach can sometimes greatly benefit our patients as he had an overall survival of 88 months despite the poor prognosis of his disease. Conclusion: To the best of our knowledge, this report is the first to describe a patient with liver metastases from clear cell gastric AC treated with interventional oncology techniques (PVE, TACE, and SIRT) in combination with other locoregional and systemic therapies thereby presenting that these interventional oncology techniques can be successfully integrated into long-term management of non-conventional liver tumors.
Ključne besede:gastric adenocarcinoma, survival, multimodality treatment
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Datum objave:07.03.2022
Založnik:BMC
Leto izida:2022
Št. strani:str. 1-8
Številčenje:Vol. 22, no. 103
PID:20.500.12556/DiRROS-15495 Novo okno
UDK:616.3
ISSN pri članku:1471-230X
DOI:10.1186/s12876-022-02150-y Novo okno
COBISS.SI-ID:112216323 Novo okno
Avtorske pravice:by Authors
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 20. 6. 2022;
Datum objave v DiRROS:15.09.2022
Število ogledov:728
Število prenosov:510
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:BMC gastroenterology
Skrajšan naslov:BMC Gastroenterol
Založnik:BioMed Central
ISSN:1471-230X
COBISS.SI-ID:2437908 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:15.09.2022

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:adenokarcinom želodca, preživetje, multimodalno zdravljenje


Nazaj